hell i was not trading this 5 years ago -- was that IPO or sever r/s..../lol
who knows
all I know now is they have a very very solid drug that the FDA likes, just needs help approving and with one part i can see, but the side effects are minimalist at worse and no danger -- just did not have enough finish the 'testing phase'
FDA is liking the drug and its potential to fast track it, and then give us more time to perfect a larger study group -- then we pass -- plain and simple
its been and its being shorted like crazy to keep us in this range -- but we are gaining confidence again and people see that and the volume shows its gaining newer ground & re-found hope
with just the revival of this chance and its opportunity -- this will be above a bck again soon IMO
3q we talk againn w/FDA -- maybe we get some good news then, or good news about the testing going well, etc and gain more
its a crap shout with risks, but worth it imho
News 
Market Data 
Discover 
AI
